Results

eNauka >  Results >  Diroximel Fumarate (DRF) in Patients With Relapsing-Remitting Multiple Sclerosis: Interim Efficacy and Safety Results From the Phase 3 EVOLVE-MS-1 Study
Title: Diroximel Fumarate (DRF) in Patients With Relapsing-Remitting Multiple Sclerosis: Interim Efficacy and Safety Results From the Phase 3 EVOLVE-MS-1 Study
Authors: Arnold, Douglas L; LaGanke, Christopher; Obradovic, Dragana V; Gudesblatt, Mark; Yang, Lili; Miller, Catherine; Leigh-Pemberton, Richard; Lopez-Bresnahan, Maria; Kandinov, Boris; Wolinsky, Jerry S
Issue Date: 2019
Publication: NEUROLOGY
ISSN: 0028-3878 Neurology Search Idenfier
Type: Conference Paper
Collation: vol. 92 br. 15
WoS-ID: 000475965902277
URI: https://enauka.gov.rs/handle/123456789/815683
Metadata source: (Preuzeto iz Nasi u WoS)
M-category: 
Mp. category will be shown later

Find the DOI

Google ScholarTM

Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.